Article

Ketamine in severe, highly treatment-resistant depression—a retrospective case study and a perspective

2024-06-07

Abstract excerpt

<p>Ketamine is a well-known and widely available general anesthetic from the 1960s that, in sub-anesthetic doses, has been adopted in a limited manner for the treatment of acute suicidality and treatment-resistant depression. Its short onset time and short duration of action make it feasible for use at outpatient clinics. In the US, it has a long history of off-label use and was officially approved for depression...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a1bde86f-c9f8-5643-9b84-0ecc867e9b97
DOI: 10.31234/osf.io/63su5

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Ketamine in severe, highly treatment-resistant depression—a retrospective case study and a perspectiveDOI 10.31234/osf.io/63su5Read

Real-world patient characteristics, treatment patterns, efficacy and safety of intramuscular ketamine treatment: a retrospective cohort studySemantic proximity Read

Sublingual Ketamine for Depression and Anxiety: A Retrospective Study of Real-World Clinical OutcomesSemantic proximity Read

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extensionSemantic proximity Read

Ketamine as an adjunctive therapy for major depression - a randomised controlled pragmatic pilot trial (Karma-Dep Trial)Semantic proximity Read

Propofol for treatment resistant depression: A randomized controlled trialSemantic proximity Read

Ketamine-assisted psychotherapy provides lasting and effective results in the treatment of depression, anxiety and post traumatic stress disorder at 3 and 6 months: Findings from a large single-arm retrospective effectiveness trialSemantic proximity Read

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.Semantic proximity Read

Treatment-resistant depression: molecular mechanisms and managementSemantic proximity Read

Ketamine Reimagined: Distinguishing Psychedelic and Psycholytic Modalities for Next-Generation Therapies.Semantic proximity Read

Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study.Semantic proximity Read

[Treatment-resistant depression: state of the art. Part I. Nosography and clinic].Semantic proximity Read

Pronounced Regional Variation in Esketamine and Ketamine Prescribing to US Medicaid PatientsSemantic proximity Read